| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.23 | 3e-10 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |